PubRank

H W Murray

Author PubWeight™ 227.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983 14.08
2 An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 1981 7.35
3 Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. J Clin Invest 1983 5.88
4 Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984 4.73
5 The macrophage as an effector cell. N Engl J Med 1980 4.30
6 Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma. J Immunol 1985 3.85
7 Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med 1984 3.73
8 Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates. J Exp Med 1979 3.72
9 Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 2000 3.72
10 Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet 1998 3.55
11 Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication. J Immunol 1983 3.49
12 Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation. J Exp Med 1980 3.43
13 Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity. J Clin Invest 1983 3.06
14 The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med 1975 3.06
15 Activation of human macrophages. Comparison of other cytokines with interferon-gamma. J Exp Med 1984 3.02
16 Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates. J Exp Med 1979 2.93
17 Serious infections from Bacillus sp. JAMA 1979 2.67
18 Streptococcus bovis bacteremia and underlying gastrointestinal disease. Arch Intern Med 1978 2.54
19 Serious infections caused by Streptococcus milleri. Am J Med 1978 2.47
20 Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma. J Immunol 1987 2.45
21 Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity. J Immunol 1982 2.42
22 Liver macrophages in murine listeriosis. Cell-mediated immunity is correlated with an influx of macrophages capable of generating reactive oxygen intermediates. J Exp Med 1985 2.37
23 Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages. J Exp Med 1981 2.22
24 Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes. J Immunol 1982 2.09
25 Murine Kupffer cells. Mononuclear phagocytes deficient in the generation of reactive oxygen intermediates. J Exp Med 1985 2.03
26 Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. J Immunol 1985 2.00
27 Lymphokine enhances oxygen-independent activity against intracellular pathogens. J Exp Med 1983 1.93
28 Circulating Borrelia burgdorferi in patients with acute Lyme disease: results of blood cultures and serum DNA analysis. J Infect Dis 1993 1.88
29 Atypical pneumonias. Med Clin North Am 1980 1.88
30 Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages. J Immunol 1986 1.87
31 Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. J Immunol 1988 1.87
32 Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production. N Engl J Med 1985 1.87
33 Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Ann Intern Med 1997 1.80
34 Malaria--the mime revisited: fifteen more years of experience at a New York City teaching hospital. Am J Med 1992 1.77
35 Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm 1979 1.72
36 Tumor cell anti-oxidant defenses. Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis. J Exp Med 1981 1.71
37 Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. J Immunol 1989 1.70
38 Salmonella infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1985 1.69
39 Regulation of arachidonic acid metabolism by macrophage activation. J Exp Med 1982 1.69
40 Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect Immun 1994 1.67
41 Patients treated for amebic liver abscess develop cell-mediated immune responses effective in vitro against Entamoeba histolytica. J Immunol 1986 1.65
42 Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice. J Exp Med 1997 1.59
43 Trial of oral miltefosine for visceral leishmaniasis. Lancet 1998 1.58
44 Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis. Ann Trop Med Parasitol 2002 1.54
45 The dynamics of granuloma formation in experimental visceral leishmaniasis. J Exp Med 1988 1.51
46 In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes. J Immunol 1987 1.51
47 Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial. BMJ 2001 1.50
48 Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. J Immunol 1985 1.50
49 Splenic cytokine responses in Indian kala-azar before and after treatment. J Infect Dis 1998 1.49
50 Septic pulmonary embolism complicating a central venous catheter. Chest 1990 1.47
51 Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. Am J Med 1988 1.45
52 Macrophage oxygen-dependent antimicrobial activity. IV. Role of endogenous scavengers of oxygen intermediates. J Exp Med 1980 1.44
53 Role and effect of TNF-alpha in experimental visceral leishmaniasis. J Immunol 1994 1.43
54 Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am J Trop Med Hyg 1997 1.43
55 Interaction of Leishmania with a macrophage cell line. Correlation between intracellular killing and the generation of oxygen intermediates. J Exp Med 1981 1.34
56 Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit. Clin Infect Dis 2002 1.33
57 Pretreatment with phorbol myristate acetate inhibits macrophage activity against intracellular protozoa. J Reticuloendothel Soc 1982 1.32
58 Coping with AIDS. The special problems of New York City. N Engl J Med 1987 1.31
59 Antimicrobial therapy in pulmonary aspiration. Am J Med 1979 1.31
60 Short-course of oral miltefosine for treatment of visceral leishmaniasis. Clin Infect Dis 2000 1.29
61 Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis. J Immunol 1984 1.25
62 Effect of hydrocortisone on macrophage response to lymphokine. Infect Immun 1982 1.23
63 Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy. Arch Intern Med 1976 1.21
64 Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis. J Infect Dis 1997 1.20
65 Treatment of idiopathic CD4 T lymphocytopenia with IL-2. Clin Exp Immunol 1999 1.19
66 The role of gamma interferon in the generation of human macrophages cytotoxic for Entamoeba histolytica trophozoites. Am J Trop Med Hyg 1987 1.19
67 Suppression of macrophage antimicrobial activity by a tumor cell product. J Immunol 1983 1.19
68 Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome. J Clin Invest 1985 1.15
69 Cytomegalovirus retinitis in adults. A manifestation of disseminated viral infection. Am J Med 1977 1.14
70 Oral treatment of visceral leishmaniasis with miltefosine. Ann Trop Med Parasitol 1999 1.13
71 Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome. Clin Pharmacol Ther 1987 1.10
72 Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis. J Infect Dis 1995 1.09
73 Staphylococcal septicemia and disseminated intravascular coagulation. Staphylococcus aureus endocarditis mimicking meningococcemia. Arch Intern Med 1977 1.09
74 Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta. J Exp Med 1988 1.08
75 Susceptibility of Entamoeba histolytica to oxygen intermediates. Mol Biochem Parasitol 1981 1.05
76 Disseminated paracoccidioidomycosis (South American blastomycosis) in the United States. Am J Med 1974 1.05
77 Interferon-gamma and Mycobacterium avium-intracellulare infection. J Infect Dis 1989 1.04
78 Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex. J Infect Dis 1996 1.03
79 Presence of a macrophage-mediated suppressor cell mechanism during cell-mediated immune response in experimental visceral leishmaniasis. Infect Immun 1986 1.02
80 Fever and pulmonary thromboembolism. Am J Med 1979 1.01
81 Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis. Arch Intern Med 1978 1.00
82 IFN-gamma and IFN-alpha induce the expression and synthesis of Leu 13 antigen by cultured human endothelial cells. J Immunol 1989 0.98
83 Mononuclear phagocyte antimicrobial and antitumor activity: the role of oxygen intermediates. J Invest Dermatol 1980 0.98
84 Macrophage activation: enhanced oxidative and antiprotozoal activity. Contemp Top Immunobiol 1984 0.96
85 Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma. J Infect Dis 1994 0.96
86 Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex. Ann Trop Med Parasitol 1998 0.96
87 Interferon-gamma treatment for Mycobacterium avium-intracellular complex bacillemia in patients with AIDS. J Infect Dis 1992 0.95
88 Isolated meningitis caused by Blastoschizomyces capitatus. J Infect Dis 1990 0.95
89 A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate. Am J Trop Med Hyg 1998 0.94
90 Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis. Trans R Soc Trop Med Hyg 2000 0.94
91 Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy. Parasitology 2005 0.94
92 Disseminated aspergillosis in a renal transplant patient: Diagnostic difficulties re-emphasized. Johns Hopkins Med J 1975 0.94
93 Pulmonary mucormycosis: one hundred years later. Chest 1977 0.94
94 Effect of treatment with interferon-gamma alone in visceral leishmaniasis. J Infect Dis 1995 0.93
95 Effector role of blood monocytes in experimental visceral leishmaniasis. Infect Immun 1993 0.92
96 Fever, rash, and muscle tenderness. A distinctive clinical presentation of disseminated candidiasis. Arch Intern Med 1978 0.91
97 Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia. Clin Nephrol 1983 0.91
98 Suppression of T-lymphocyte responses to Entamoeba histolytica antigen by immune sera. Infect Immun 1990 0.90
99 Preschool programs and later school competence of children from low-income families. Science 1980 0.90
100 Circulating interferon-gamma in AIDS patients treated with interleukin-2. N Engl J Med 1988 0.89
101 Antigen-induced human interferon-gamma production. Differential dependence on interleukin 2 and its receptor. J Immunol 1987 0.88
102 How protozoa evade intracellular killing. Ann Intern Med 1983 0.87
103 Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice. Infect Immun 1990 0.87
104 Why is Listeria monocytogenes not a pathogen in the acquired immunodeficiency syndrome? Arch Intern Med 1986 0.86
105 Bacterial invasion of pulmonary vessels. Pseudomonas bacteremia mimicking pulmonary thromboembolism with infarction. Am J Med 1978 0.86
106 Induction of macrophage antiprotozoal activity by monocyte chemotactic and activating factor. FEMS Immunol Med Microbiol 1996 0.86
107 Antigen-stimulated human interferon-gamma generation: role of accessory cells and their expressed or secreted products. Clin Exp Immunol 1989 0.85
108 Septic bursitis. Ann Intern Med 1978 0.85
109 Pulmonary mucormycosis with massive fatal hemoptysis. Chest 1975 0.85
110 Letter: Cardiac Munchausen syndrome. Ann Intern Med 1974 0.85
111 Quinacrine-induced psychiatric disturbances. South Med J 1982 0.85
112 Nafcillin therapy for Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 1978 0.84
113 Onchocerciasis in New York City. The Moa-Manhattan connection. Arch Intern Med 1994 0.84
114 Liver biopsy septicemia. Gastroenterology 1977 0.84
115 Transient autoimmune hemolytic anemia and pulmonary tuberculosis. N Engl J Med 1978 0.83
116 Human immunodeficiency virus infection and bacteremic meningococcal pneumonia. J Infect Dis 1991 0.83
117 Cellular resistance to protozoal infection. Annu Rev Med 1986 0.82
118 Kala-azar comes to New York. Arch Intern Med 1997 0.82
119 Candida arthritis. A manifestation of disseminated candidiasis. Am J Med 1976 0.81
120 Unusual manifestation of tuberculosis: TE fistula. Am J Med 1976 0.81
121 Arizona hinshawii osteomyelitis with antecedent enteric fever and sepsis. A case report with a review of the literature. Am J Med 1976 0.81
122 Letter: "Goalpost fever". Ann Intern Med 1975 0.81
123 Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma. Am J Trop Med Hyg 1993 0.81
124 Macrophage oxygen-dependent killing of intracellular parasites: Toxoplasma and Leishmania. Adv Exp Med Biol 1983 0.80
125 Not everything that glitters is Lyme disease. Am J Med 1992 0.80
126 Fever with dissecting aneurysm of the aorta. Am J Med 1976 0.80
127 Ventriculoatrial shunting for hydrocephalus complicating tuberculous meningitis. Am J Med 1981 0.80
128 The adult respiratory distress syndrome associated with miliary tuberculosis. Chest 1978 0.79
129 Lymphocyte proliferation assay in Lyme disease. J Infect Dis 1992 0.79
130 Accessory cell function of AIDS monocytes. J Infect Dis 1987 0.79
131 Gamma interferon in the treatment of Kala-azar and other forms of Leishmaniasis. J Assoc Physicians India 1995 0.79
132 Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis. Am J Trop Med Hyg 1996 0.78
133 Interferon-gamma in infection and immunoparalysis. Intensive Care Med 1996 0.78
134 Lymphokine stimulated macrophages inhibit intracellular Chlamydia psittaci replication by mechanisms distinct from intracellular inhibition of Toxoplasma gondii replication. Adv Exp Med Biol 1983 0.77
135 Aspergillosis. JAMA 1977 0.77
136 Therapeutic effect of interferon-gamma gene transfer in experimental visceral leishmaniasis. J Infect Dis 1998 0.77
137 Tuberculous meningitis in a puerperal woman. JAMA 1980 0.77
138 Delivery of human interferon-gamma via gene transfer in vitro: prolonged expression and induction of macrophage antimicrobial activity. J Interferon Cytokine Res 1996 0.76
139 Colorado tick fever in a resident of New York City. Arch Fam Med 1994 0.76
140 Drug fever induced by heparin. Am J Med 1992 0.76
141 Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis. J Assoc Physicians India 1999 0.76
142 Interleukin-2 treatment, interferon-gamma induction, and AIDS monocyte activation. Am J Med 1992 0.76
143 Treatment of kala-azar with oral fluconazole. Lancet 1996 0.76
144 Monocytes in HIV infection. Rev Infect Dis 1989 0.75
145 Opportunistic infections and impaired cell-mediated immune responses in patients with the acquired immune deficiency syndrome. Trans Am Clin Climatol Assoc 1984 0.75
146 The local cellular immune response in experimental leishmaniasis. Ann Inst Pasteur Immunol 1988 0.75
147 CMV retinitis. Br Med J 1976 0.75
148 Letter: Roentgenographically atypical Pneumocystis carinii pneumonia. Am Rev Respir Dis 1975 0.75
149 Uveitis and the immunologically compromised host. N Engl J Med 1978 0.75
150 Is the appendix boring? Arch Intern Med 1981 0.75
151 Use of granulocyte-macrophage colony stimulating factor for treatment of drug-induced agranulocytosis. Rev Infect Dis 1991 0.75
152 Spontaneous bacterial empyema, pericarditis, and peritonitis in cirrhosis. Gastroenterology 1977 0.75
153 Mycoplasma pneumoniae infection. Arch Intern Med 1980 0.75
154 Retinitis: a manifestation of primary or secondary cytomegalovirus infection? Arch Intern Med 1978 0.75
155 Pulmonary edema in malaria. Int J Infect Dis 1999 0.75
156 Family planning in a rural nurse-midwifery program;. Fam Plann Perspect 1973 0.75
157 In vitro granuloma formation in experimental visceral leishmaniasis. J Infect Dis 1987 0.75
158 Colovesical fistula. JAMA 1979 0.75
159 Immunologic developments in AIDS--1985. Year Immunol 1986 0.75
160 Urinary temperature: a clue to early diagnosis of factitious fever. N Engl J Med 1977 0.75
161 Unusual pleocytosis in aseptic meningitis. N Engl J Med 1977 0.75
162 Cellular immunity and the acquired immune deficiency syndrome: failure to secrete lymphokines and gamma interferon. Surv Synth Pathol Res 1984 0.75
163 Fever of undetermined origin. Arch Intern Med 1979 0.75
164 Factitious fever updated. Arch Intern Med 1979 0.75
165 Letter: Allergic reactions to amphotericin B. N Engl J Med 1974 0.75
166 Fatal retroperitoneal hemorrhage. An unusual complication of renal cortical abscess. JAMA 1979 0.75
167 Immunologic developments in AIDS--1984. Year Immunol 1985 0.75
168 Appendicitis with perforation: a reminder to internists. South Med J 1980 0.75
169 Fungal cholecystitis and AIDS. J Infect Dis 1990 0.75